FDA to Require Boxed Warning for Montelukast

FDA to Require Boxed Warning for Montelukast

By Gary Fitzgerald Allergy & Asthma Network’s voices were heard – the U.S. Food and Drug Administration (FDA) announced it is requiring a boxed warning for montelukast due to mental health, behavior and mood-related changes associated with the medication. “Allergy...
Photo of Cannabis products

The survey is for BOTH users and non-users of cannabis. It does not matter if you have ever used cannabis, used cannabis in the past, or currently use cannabis. The survey is confidential and anonymous.

You have Successfully Subscribed!